ESLA
Price
$2.20
Change
+$0.10 (+4.76%)
Updated
Nov 13 closing price
Capitalization
80.99M
Intraday BUY SELL Signals
PRLD
Price
$1.51
Change
+$0.04 (+2.72%)
Updated
Nov 13 closing price
Capitalization
85.47M
124 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ESLA vs PRLD

Header iconESLA vs PRLD Comparison
Open Charts ESLA vs PRLDBanner chart's image
Estrella Immunopharma
Price$2.20
Change+$0.10 (+4.76%)
Volume$208.89K
Capitalization80.99M
Prelude Therapeutics
Price$1.51
Change+$0.04 (+2.72%)
Volume$817.34K
Capitalization85.47M
ESLA vs PRLD Comparison Chart in %
ESLA
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ESLA vs. PRLD commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLA is a Buy and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ESLA: $2.20 vs. PRLD: $1.51)
Brand notoriety: ESLA and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ESLA: 68% vs. PRLD: 49%
Market capitalization -- ESLA: $80.99M vs. PRLD: $85.47M
ESLA [@Biotechnology] is valued at $80.99M. PRLD’s [@Biotechnology] market capitalization is $85.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLA’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • ESLA’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than ESLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLA’s TA Score shows that 3 TA indicator(s) are bullish while PRLD’s TA Score has 4 bullish TA indicator(s).

  • ESLA’s TA Score: 3 bullish, 5 bearish.
  • PRLD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ESLA and PRLD are a bad buy in the short-term.

Price Growth

ESLA (@Biotechnology) experienced а -20.29% price change this week, while PRLD (@Biotechnology) price change was +11.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

PRLD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRLD($85.5M) has a higher market cap than ESLA($81M). ESLA YTD gains are higher at: 75.000 vs. PRLD (15.294). ESLA has higher annual earnings (EBITDA): -8.82M vs. PRLD (-133.25M). PRLD has more cash in the bank: 73.2M vs. ESLA (1.32M). PRLD has higher revenues than ESLA: PRLD (7M) vs ESLA (0).
ESLAPRLDESLA / PRLD
Capitalization81M85.5M95%
EBITDA-8.82M-133.25M7%
Gain YTD75.00015.294490%
P/E RatioN/AN/A-
Revenue07M-
Total Cash1.32M73.2M2%
Total DebtN/A17.9M-
TECHNICAL ANALYSIS
Technical Analysis
ESLAPRLD
RSI
ODDS (%)
Bearish Trend 3 days ago
40%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
39%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
49%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
46%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ESLA
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPCPY22.970.13
+0.57%
KASIKORNBANK Public Co. Ltd.
AVCVF0.10N/A
N/A
Monitor Ventures Inc.
OQLGF2.30N/A
N/A
Olympique Lyonnais Groupe
LIOPY16.40N/A
N/A
Lion Corp.
RGCCF0.30N/A
-1.03%
RELEVANT GOLD CORP

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and PRLD have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and PRLD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
-16.33%
PRLD - ESLA
26%
Poorly correlated
+8.89%
TERN - ESLA
24%
Poorly correlated
-1.36%
CYTOF - ESLA
23%
Poorly correlated
+7.53%
FATE - ESLA
23%
Poorly correlated
-7.14%
CMND - ESLA
23%
Poorly correlated
-32.32%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with NAUT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+8.89%
NAUT - PRLD
47%
Loosely correlated
+4.22%
MLTX - PRLD
35%
Loosely correlated
+8.68%
AMRN - PRLD
35%
Loosely correlated
+0.75%
AXON - PRLD
35%
Loosely correlated
-0.47%
IMNM - PRLD
34%
Loosely correlated
-0.51%
More